ALCY SPAC: $12.25M in trust but limited cash, going‑concern as Aug 22 business combo announced

Alchemy Investments Acquisition Corp 1 (NASDAQ: ALCY)

Short take - ALCY is a blank‑check (SPAC) company that has not commenced operating activities. It holds most proceeds in a Trust Account invested in U.S. Treasury securities and is actively pursuing an initial business combination. The company reported a material going‑concern warning driven by very limited cash outside the trust and near‑term deadlines; however, a Business Combination Agreement was announced as a subsequent event (Aug 22, 2025).

Key facts & figures (as reported June 30, 2025)
* Total assets: $12,503,259
* Investments held in Trust Account: $12,252,250 (U.S. Treasury securities, Level 1)
* Cash and cash equivalents (outside Trust): $161,205
* Total current liabilities: $2,756,442 - Total liabilities: $7,931,442
* Deferred underwriting fee payable: $5,175,000
* Class A ordinary shares subject to possible redemption (redemption value): $12,152,249
* Class A shares issued and outstanding: 4,532,462 (includes 1,061,963 subject to redemption)
* Warrants outstanding (Public): 5,750,000
* Accumulated deficit: $(7,580,780)
* Promissory note - related party outstanding: $1,130,000 (interest accrual $84,472 as of 6/30/25)
* Six months ended June 30, 2025 - Net loss: $(521,753); Operating & formation costs: $722,490; Gain on investments in Trust Account: $250,442; Dividend income: $6,795; Interest expense (related party): $56,500
* Net cash used in operating activities (six months): $(619,969)
* Working capital deficit: $2,505,433
* Extension deposits held in Trust for deadline extension: $240,000 (included in Trust Account)

Positive aspects (income statement & balance sheet)
* Trust investments produced positive investment gains ($250,442 for six months) and are invested in high‑quality U.S. Treasury securities (low market/credit risk).
* Successful IPO raised $115,000,000 (proceeds placed in Trust Account); after prior redemptions the Trust still holds material assets ($12.25M as of 6/30/25).
* Company documented and disclosed extension deposits and committed sponsor support (promissory notes and working capital loans) to continue pursuit of target.
* Subsequent event: Business Combination Agreement entered on Aug 22, 2025 (with Cartiga) - a clear milestone toward completing a business combination.

Negative aspects / risks (income statement & overall financial position)
* Core operating loss: six‑month net loss $(521,753) driven by operating costs ($722,490); operating cash burn is meaningful relative to non‑trust cash ($161,205).
* Extremely limited liquidity outside of Trust Account - cash of $161,205 vs. working capital deficit $2,505,433; management states cash outside the Trust is insufficient to operate for at least one year → substantial doubt about going concern.
* Heavy reliance on related‑party financing: promissory notes of $1,130,000 and accrued related‑party interest; sponsor loans are not a durable source of capital.
* Large deferred underwriting fee ($5,175,000) and the potential for redemptions (1,061,963 shares valued at $12,152,249) can materially reduce funds available to the post‑combination company.
* Investment gains were much lower in 2025 vs. 2024 (six months: $250,442 in 2025 vs. $3,165,435 in 2024) - swing turned a prior period net income ($2,727,570 six months 2024) into a loss in 2025.
* Deadlines and execution risk: Company must complete a Business Combination by the Extended Date (September 9, 2025) or liquidate - though the company obtained month‑to‑month extension authority and is making extension deposits; failure would likely cause liquidation and warrants would expire worthless.

What to watch next (investor checklist)
* Confirm terms and expected close timing of the Aug 22, 2025 Business Combination Agreement (deal economics, cash bridge, dilution, redemptions).
* Monitor cash outside the Trust, any additional sponsor loans or financing, and whether deferred underwriting fees are paid from the Trust on closing.
* Watch actual redemption levels at the time of the business combination - high redemptions will reduce available deal financing.
* Track updates to the going‑concern statement and any new financing or bridge facilities announced by the company.
* Review post‑combination capitalization (shares, warrants, converted founder shares) to assess investor dilution and enterprise liquidity.

Bottom line: ALCY holds meaningful trust assets and has taken steps toward a deal (Business Combination Agreement announced), but very limited operating cash, a working capital deficit and related‑party debt create short‑term liquidity and execution risk. The upcoming deal terms and the level of redemptions will determine whether this SPAC converts into a viable operating company or faces liquidation risk.